Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Audio Summaries
Every issue of Clinical infectious diseases : an official publication of the Infectious Diseases Society of America moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Specialties
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America covers research in these specialties.
Recent summaries
The latest articles summarized from Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Clinical Impact of the BIOFIRE® FILMARRAY® Pneumonia Panel in the Veterans Affairs Healthcare System: A Difference-in-Differences Study
Jun 12, 2026
The authors aimed to evaluate the clinical impact of the BIOFIRE® FILMARRAY® Pneumonia Panel on antibiotic optimization and patient outcomes in ICU patients with pneumonia within the Veterans Affairs Healthcare System. Their study found that implementation of the PN Panel was associated with improved early antimicrobial de-escalation and appropriate therapy, particularly in hospitals with robust antimicrobial stewardship programs, although overall mortality rates did not differ significantly.
Cost-effectiveness of Commercial or Traditional Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
Jun 11, 2026
The authors aimed to evaluate the cost-effectiveness of commercial, FDA-approved microbiota therapeutics compared to traditional fecal microbiota transplantation (FMT) via colonoscopy for managing recurrent Clostridioides difficile infection (rCDI). Their findings indicate that traditional FMT is the most cost-effective strategy, with an incremental cost-effectiveness ratio of $44,158, while commercial microbiota therapeutics are not cost-effective when donor-derived FMT is available. Overall, the study concludes that colonoscopic FMT remains the optimal approach for preventing subsequent rCDI episodes.
Oral Wash PCR Improves the Diagnosis of Pneumocystis Pneumonia in Immunocompromised Patients Without HIV: A Prospective Multicenter Study
Jun 11, 2026
The authors aimed to evaluate the effectiveness of oropharyngeal wash (OW) PCR as a diagnostic tool for Pneumocystis pneumonia (PCP) in HIV-negative immunocompromised patients, comparing it to traditional bronchoalveolar lavage (BAL). Their prospective multicenter study found that OW PCR demonstrated a high positive rate in confirmed PCP cases and provided a non-invasive alternative for diagnosis, achieving a positive predictive value of 78.5%. The study concluded that OW PCR is a valuable method for diagnosing PCP in this patient population, particularly when BAL may be poorly tolerated.